43
Open an Account  | Login  | Demo
Tuesday, February 12, 2008
Real news in Real Time! National and international updates on all products by leading agencies such as Dow Jones, Capital Markets, Commodities Control and more.
Equity   |   Derivatives   |   IPO   |   Commodity   |   Mutual Funds   |   Forex   |   Insurance   |   Mobile

OVERVIEW

Capital Market Live News    Dow Jones News Wire    Derivatives/F&O News    Advanced Search   
Commodity News    Forex News   


Equity News
Feb 11 2008 2:40PM
Panacea Biotec inaugurates GRAND- fifth R&D; centre at Navi Mumbai
Panacea Biotec has announced that the company has opened it's world class, state of the art - Global Research & Development (GRAND) Centre in Navi Mumbai on February 11th. The facility was inaugurated by its chairman, Soshil Kumar Jain. This is the fifth R&D; centre which has been set up with a vision to be a global leader in the delivery of conventional and biotech based drugs for unmet therapeutic needs of safety, efficacy and compliance involving world class science. The other four R&D; centres at Lalru, Delhi and Mohali, focus on drug delivery (pharmaceuticals), vaccines, drug discovery (bio-pharmaceuticals) and drug discovery (small molecules). With this the combined strength of people dedicated to drive innovation in R&D; has gone up to 350. Panacea Biotec invests around 6% of it's annual turnover into research & development.

The company made this announcement during the traidng hours today, 11 February 2008.

Powered byCapital Market - Live News
  Source:   

   Capital Market Disclaimer
Back
 
 
News
 
Research
 
Markets
 
Knowledge Center
 
Charting
 
Customer Service
 
Contact Us
 
Site Map
 
SEBI | BSE | NSE
Terms & Conditions | Disclaimer | Online Privacy | Trouble Logging in
Copyright© 2007. All rights Reserved. Reliance Money Limited
Equities: Trading through Reliance Securities Limited | NSE SEBI Registration Number Capital Market :- INB 231234833 | BSE SEBI
Registration Number Capital Market :- INB 011234839 | NSE SEBI Registration Number Derivatives :- INF 231234833 Commodities : Trading through Reliance Commodities Limited | MCX member code: 29030 | NCDEX member code: NCDEX-CO-05-00647|
NMCE member code: CL0120 Mutual Funds : Reliance Securities Limited | AMFI ARN No.29889
In case of any grievances please write to [email protected]
In case of any queries/ complaints with respect to stock broking transactions executed on this website or pertaining account opening, Pl.address your correspondence to Reliance Securities Limited.